MolPort-001-840-190

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 8 USDMF, 4 CEP/COS, 1 EU WC, 1 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 11 FDA Orange Book, 31 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 13 SPI Pharma, 2 Seqens, 7 DKSH, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 2 Finar, 5 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 28 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Film Formers & Plasticizers, 14 Taste Masking, 13 Topical, 13 Parenteral, 12 Thickeners and Stabilizers, 12 Chewable & Orodispersible Aids, 11 Direct Compression, 9 Empty Capsules, 8 Solubilizers, 6 Granulation, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Co-Processed Excipients, 4 Disintegrants & Superdisintegrants, 2 Emulsifying Agents, 2 Rheology Modifiers, 1 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

10 NEWS #PharmaBuzz

10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 25 Finished Drug Prices

MARKET PLACE

9 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 3 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 203340 / DOSAGE - SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
nimodipine(UNII: 57WA9QZ5WH) (nimodipine - UNII:57WA9QZ5WH)	nimodipine	30mg in 10 \| 60mg in 20

Inactive Ingredients

Ingredient Name	Arbor Pharmaceuticals
alcohol(3K9958V90M)
glycerin(PDC6A3C0OX)
methylparaben(A2I8C7HI9T)
polyethylene glycol 400(B697894SGQ)
sodium phosphate, dibasic, unspecified form(GR686LBA74)
sodium phosphate, monobasic, unspecified form(3980JIH2SW)
water(059QF0KO0R)

Drug Product Composition: MolPort-001-840-190